ImmuOn Therapeutics and Argus Pharmaceutical have entered an agreement to collaborate in biological production and marketing.

ImmuOn is specialized in research and development of adult prophylactic and therapeutic vaccines, as well as immune simulative biologicals. Argus is specialized in fermentation and manufacture and biologically active peptides and proteins.

Both parties will be working together to develop and market biological medicines including vaccines and other biologicals currently under development.